Integrin-linked kinase 1: Role in hormonal cancer progression

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 2, 2011, Pages 788-796

  Cortez, Valerie ^a,b   Nair, Binoj C ^a,b   Chakravarty, Dimple ^a   Vadlamudi, Ratna K ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

AKT; EMT; ErbB2; Estrogen receptor; Hormonal signaling; Integrin linked kinase; Metastasis; Therapy resistance

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; INTEGRIN LINKED KINASE; INTEGRIN LINKED KINASE 1; TAMOXIFEN; UNCLASSIFIED DRUG; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL DEATH; GENE OVEREXPRESSION; GENE TARGETING; HORMONAL THERAPY; HUMAN; METASTASIS; NONHUMAN; OVARY CANCER; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THERAPY RESISTANCE; DISEASE COURSE; DRUG ANTAGONISM; ENDOPLASMIC RETICULUM; ENZYMOLOGY; GENETICS; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; HUMANS; NEOPLASM METASTASIS; NEOPLASMS, HORMONE-DEPENDENT; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 79955964381     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. S Persad, S Dedhar. The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 22, 375-384 (2003) (Pubitemid 36791893)
2. GE Hannigan, C Leung-Hagesteijn, L Fitz-Gibbon, MG Coppolino, G Radeva, J Filmus, JC Bell, S Dedhar. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379, 91-96 (1996) (Pubitemid 26008142)
3. S Dedhar, B Williams, G Hannigan. Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol 9, 319-323 (1999) (Pubitemid 29339148)
4. PC. McDonald, AB Fielding, S Dedhar. Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 121, 3121-3132 (2008)
5. JT Deng, JE Van Lierop, C Sutherland, MP Walsh. Ca2+- independent smooth muscle contraction. a novel function for integrin-linked kinase. J Biol Chem 276, 16365-16373 (2001)
6. M Delcommenne, C Tan, V Gray, L Rue, J Woodgett, S Dedhar. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95, 11211-11216 (1998) (Pubitemid 28450107)
7. Y Tu, F Li, S Goicoechea, C Wu. The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol 19, 2425-2434 (1999) (Pubitemid 29098300)
8. SN Nikolopoulos, CE Turner. Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J Biol Chem 276, 23499-23505 (2001)
9. Mongroo P.S. Johnstone,C.N. Naruszewicz,I. Leung- Hagesteijn,C. Sung,R.K. Carnio,L. Rustgi,A.K. & Hannigan,G.E. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer. Oncogene. 23, 8959-8970 (2004) (Pubitemid 39657786)
10. S Yamaji. A Suzuki, Y Sugiyama, Y Koide, M Yoshida, H Kanamori, H Mohri, S Ohno, Y Ishigatsubo. A novel integrin-linked kinase-binding protein, a ffixin, is involved in the early stage of cell-substrate interaction. J Cell Biol 153, 1251-1264 (2001) (Pubitemid 34289263)
11. Y Tu, Y Huang, Y Zhang, Y Hua, C Wu. A new focal adhesion protein that interacts with i ntegrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153, 585-598 (2001) (Pubitemid 34280144)
12. Acconcia F. Barnes,C.J. Singh,R.R. Talukder,A.H. & Kumar,R. Phosphorylation-dependent regulation o f nuclear localization and functions of integrin-linked kinase. Proc. Natl. Acad. Sci. U. S. A. 104, 6782-6787 (2007) (Pubitemid 47175578)
13. F Acconcia, B Manavathi, J Mascarenhas, AH Talukder, G Mills, R Kumar. An inherent role of integrinlinked kinase-estrogen receptor alpha interaction in cell migration. Cancer Res 66, 11030-11038 (2006) (Pubitemid 44877003)
14. Z Mi, H Guo, PY Wai, C. Gao, PV Kuo. Integrin-linked ki nase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Carcinogenesis 27, 1134-1145 (2006) (Pubitemid 43985428)
15. H Sawai, Y Okada, H, Funahash i, Y Matsuo, H, Takahashi, H, Takeyama, T. Manabe. Integrin-linked kinase activity is associated with interleukin-1 alphainduced progressive behavior of pancreatic cancer and poor patient survival. Oncogene 25, 3237-3246 (2006) (Pubitemid 43846308)
16. D Chakravarty, RR Tekmal, RK Vadlamudi. PELP1: A novel therapeutic target for hormonal cancers. IUBMB Life 62, 162- 169 (2010)
17. A. Oloumi, S Syam, S Dedhar. Modulation of Wnt3amediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene 25, 7747-7757 (2006) (Pubitemid 44967969)
18. S Persad, S Attwell, V Gray, M Delcommenne, A, Troussard, J Sanghera, S Dedhar. Inhibition of integrinlinked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTENmutant prostate cancer cells. Proc Natl Acad Sci USA 97, 3207-3212 (2000) (Pubitemid 30183280)
19. C Leung-Hagesteijn, A Mahendra, I Narusz ewicz, GE Hannigan. Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J 20, 2160-2170 (2001) (Pubitemid 32410586)
20. AS Kumar, I Narusz ewicz, P Wang, C Leung- Hagesteijn, GE Hannigan. ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene 23, 3454-3461 (2004) (Pubitemid 38669835)
21. MS Weaver, G Workman, EH Sage. The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase. J Biol Chem 283, 22826-22837 (2008)
22. G Hannigan, AA Troussard, S Dedhar. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5, 51-63 (2005) (Pubitemid 40052325)
23. G Radeva, T Petrocelli, E, Behrend, C, Leung- Hagesteijn, J Filmus, J Slingerland, S Dedhar. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 272, 13937-13944 (1997) (Pubitemid 27224838)
24. S Attwell, C Roskelley, S, Dedhar. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19, 3811-3815 (2000) (Pubitemid 30621188)
25. C Wu. SY Keightley, C, Leung-Hagesteijn, G, Radeva, M, Coppolino, S Goicoechea, JA McDonald, S D edhar. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273, 528-536 (1998) (Pubitemid 28042241)
26. J.R. Graff, J.A. Deddens, B.W. Konicek, B.M. Colligan, B.M. Hurst, H.W. Carter, J.H. Carter. Integrinlinked kinase expression increases with prostate tumor grade. Clin Cancer Res 7, 1987-19 91 (2001) (Pubitemid 32994836)
27. AA Troussard, PC. McDonald, ED Wederell, NM Mawji, NR Filipenko, KA Gelmon, JE Kucab, SE Dunn, JT Emerman, MB Bally, S Dedhar. Preferential dependence of breast cancer cells ve rsus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res 66, 393-403 (2006) (Pubitemid 43166047)
28. BW Robertson, MA Chellaiah. Osteopontin induces beta-catenin signaling through activation of Akt in prostate cancer cells. Exp. Cell Res 316, 1- 11 (2010)
29. DD Sarbassov, SM Ali, DH Kim, DA Guertin, RR Latek, H Erdjument-Bromage, P Tempst, DM Sab atini. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14, 1296-1302 (2004) (Pubitemid 38991819)
30. PC McDonald. A Oloumi, J Mills, I Dobreva, M Maidan, V Gray, ED Wederell, MB Bally, LJ Foster, S Dedhar. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 68, 161 8-1624 (2008) (Pubitemid 351416544)
31. DE White, RD Cardiff, S Dedhar, WJ Muller. Mammary epithelial-specific expression of the integrinlinked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgeni c mice. Oncogene 20, 7064-7072 (2001) (Pubitemid 33052198)
32. CG Zervas, SL Gregory, NH Brown. Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol 152, 1007-1018 (2001) (Pubitemid 34286076)
33. AC Mackinnon, H Qadota, KR Norman,DG Moerman, BD Williams. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 12, 787-797 (2002) (Pubitemid 34514364)
34. T Sakai, S Li, D Docheva, C Grashoff, K Sakai, G Kostka, A Braun, A Pfeifer, PD Yurchenco, R, Fassler. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling act in accumulation. Genes Dev 17, 926-940 (2003) (Pubitemid 36397379)
35. C Tan, S, Cruet-Hennequart, A, Troussard, L Fazli, P Costello, K Sutton, J Wheeler, M, Gleave, J Sanghera, S, Dedhar. Regulation of tumor angiog enesis by integrinlinked kinase (ILK) Cancer Cell. 5, 79-90 (2004) (Pubitemid 38121598)
36. Y Kaneko, K Kitazato, Y Basaki. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor. J. Cell Sci. 117, 407-415 (2004) (Pubitemid 38181202)
37. S.W. Lin, FC Ke, PW Hsiao, PP Lee, MT Lee, JJ Hwang. Critical involvement of ILK in TGFbeta1- stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Exp Cell Res 313, 602-613 (2007)
38. MJ Barbera, I Puig, D Dominguez, S Julien-Grille, S Guaita-Esteruelas, S Peiro, J Baul ida, C Franci, S Dedhar, L Larue, H.A. Garcia de. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene. 23, 7345-7354 (2004) (Pubitemid 39382137)
39. A Somasiri, A Howarth, D, Goswami, S Dedhar, C.D. Roskelley. Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci 114, 1125-1136 (2001) (Pubitemid 32288526)
40. Y Li, J Y ang, C Dai, C Wu, Y Liu. Role for integrinlinked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112, 503-516 (2003) (Pubitemid 38056335)
41. N Ahme d, C Riley, K Oliva, E Stutt, GE Rice, MA Quinn. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol 201, 229-237 (2003) (Pubitemid 37258934)
42. D Los sner, C Abou-Ajram, A Benge, M, Aumercier, M, Schmitt, U Reuning. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription. J. Cell Physiol 220, 367-375 (2009)
43. N Ahmed, K Oliva, GE Rice, MA Quinn. Cell-free 59 kDa immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma. Clin Cancer Res 10, 2415-2420 (2004) (Pubitemid 38445701)
44. N Kieffer, M Schmitz, S, Plancon, C Margue, F Huselstein, G, Grignard, W Dippel, M, Nathan, S Giacchi, R Scheiden. ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA is olation from frozen prostate biopsy tissue sections. Int J Oncol 26, 1549-1558 (2005)
45. L Rosano, F Spinella, C Di, S Dedhar, MR Nicotra, PG Natali, A Bagnato. Integrin-linked kinase fu nctions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol. Cancer Ther 5, 833-842 (2006) (Pubitemid 43724582)
46. G Hoffmann, K Pollow, W Weikel, HJ Strittmatter, J Bach, M, Schaffrath, P Knapstein, F, Melchert, B Pollow. Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological paramete rs. Clin Chem Lab Med 37, 47-54 (1999) (Pubitemid 29097253)
47. Y Oda, Y Ohishi, Y Basaki, H Kobayashi, T Hirakawa, N Wake, M Ono, K Nishio, M Kuwano, M Tsuneyoshi. Prognostic implications of the nuclear localization of Ybox- binding protein-1 and CXCR4 expr ession in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression. Cancer Sci 98, 1020-1026 (2007) (Pubitemid 46865386)
48. Y Basaki, F Hosoi, Y Oda, A Fotovati, Y Maruyama, S Oi e, M Ono, H Izumi, K Kohno, K Sakai, T Shimoyama, K Nishio, M Kuwano. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 26, 2736-2746 (2007) (Pubitemid 46663838)
49. A Novak, SC Hsu, C Leung-Hagesteijn, G Radeva, J. Papkoff, R, Montesano, C Roskelley, R Grosschedl, S Dedhar. Cell adhesion and the integrin-linked kinase regula te the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA 95, 4374-4379 (1998)
50. SM Frisch, E Ruoslahti,E. Integrins and anoikis. Curr Opin Cell Biol 9, 701-706 (1997) (Pubitemid 27424927)
51. AA Troussard, P Costello, TN Yoganathan, S Kumagai, CD. Roskelley, S Dedhar. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9) Oncogene 19, 5444-5452 (2000) (Pubitemid 32000911)
52. SC. Wang, K Makino, W Xia, JS Kim, SA Im, H Peng, SC Mok, SE Singletary, MC Hung. DOC-2/hDab-2 inhibits ILK act ivity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene. 20, 6960-6964 (2001) (Pubitemid 33052186)
53. HO Habashy, DG Powe, EA Rakha, G Ball, RD Macmillan, AR Green, IO Ellis. Th e prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Res Treat 120, 603-12 (2009)
54. D Chakravarty. SS Nair, B Santhamma , BC Nair, L Wang, A Bandyopadhyay, JK Agyin, D Brann, LZ. Sun, IT Yeh, FY Lee, RR Tekmal, R Kumar, RK Vadlamudi. Extranuclear Functions of ER Impact Invasive Migration and Metastasis by Breast Cancer Cells. Cancer Res 70, 4092-101 (2010)
55. S Sakamoto, RO McCann, R Dhir, N Kyprianou. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 70, 1885 -1895 (2010)
56. S Kanayama, Y Yamada, R Kawaguchi, Y Tsuji, S Haruta, H Kobayashi. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 express ion in uterine endometrial cancer cells. Oncol Rep 19, 117-122 (2008) (Pubitemid 351176139)
57. S Srivastava, B Ramdass, S Nagarajan, M Rehman, G Mukherjee, S Krishna. Notch1 regulates the functional contribut ion of RhoC to cervical carcinoma progression. Br J Cancer 102, 196-205 (2010)
58. F Acconcia, R Kumar,R. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 238, 1-14 (2005)
59. R Schiff, SA Massarweh, J Shou, L Bharwani, G Arpino, M Rimawi, CK Osborne. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistanc e: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother Pharmacol 56 Suppl 1:10-20., 10-20 (2005)
60. PK Marcom, C Isaacs, L Harris, ZW Long, A Kommarreddy, N Novielli, G Mann, Y Tao, MJ Ellis. The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancer s. Breast Cancer Res Treat. 102, 43-49 (2007) (Pubitemid 46294957)
61. SM Pontier, L Huck, DE White, J Rayment, V Sanguin- Gendreau, B Hennessy, D Zuo, R St-Arnaud, GB Mills, S, Dedhar, CJ Marshall, WJ Muller. Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene (2010)
62. E. Tokunaga, A Kataoka, Y Kimura, E Oki, K Mashino, K Nishida, T Koga, M Morita, Y Kakeji, H Baba, S Ohno, Y Maehara. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur J Cancer 42, 629-635 (2006) (Pubitemid 43343685)
63. PR Molli, DQ Li, BW Murray, SK Rayala, R Kumar. PAK signaling in oncogenesis. Oncogene 28, 2545-2555 (2009)
64. SK Rayala, PR Molli, R Kumar. Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity. Cancer Res 66, 5985-5988 (2006)
65. Y Ishii, S Waxman, D Germain. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3. Cancer Res 68, 852-860 (2008) (Pubitemid 351206763)
66. M D'Amico, J Hulit, DF Amanatullah, BT Zafonte, C Albanese, B Bouzahzah, M Fu, LH Au genlicht, LA Donehower, K Takemaru, RT Moon, R Davis, MP Lisanti, M Shtutman, J Zhurinsky, A Ben-Ze'ev, AA Troussard, S Dedhar, RG Pestell. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 20;275, 32649-32657 (2000)
67. R Kumar, H Zhang, C Holm, RK Vadlamudi, G Landberg, SK Rayala. Extranuclear coactivator signaling confers insensitivity to tamoxifen. Clin Cancer Res 15, 4123-4130 (2009)
68. J Kalra, C Warburton, K Fang, L Edwards, T Daynard, D Waterhouse, W Dragowsk a, BW Sutherland, S Dedhar. K Gelmon, M Bally. QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P- AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model. Breast Cancer Res 11, R25 (2009)
69. Q Li, YH Zhang, PL Li, JR Pei. Inhibitory effect of antisense oligonucleotide of integrin-linked kinase on cell proliferation of human epithelial ovarian cancer. Zhonghua Fu Chan Ke. Za Zhi 43, 218-222 (2008)
70. C Tan, P Costello, J Sanghera, D Do minguez, J Baulida, AG de Herreros, S Dedhar. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcfdependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene 20, 133-140 (2001) (Pubitemid 32142346)
71. I Eke, F Leonhardt, K Storch, S Hehlgans, N Cordes. The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck. PLoS One 4, e6434 (2009)